AbbVie Inc.ABBVNYSE
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank64
5Y CAGR+110.6%
Year-over-Year Change
Year-over-year debt growth rate
5Y CAGR
+110.6%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
41.5x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.19% |
| Q3 2025 | -2.47% |
| Q2 2025 | 0.85% |
| Q1 2025 | 3.02% |
| Q4 2024 | -4.56% |
| Q3 2024 | 0.63% |
| Q2 2024 | -4.55% |
| Q1 2024 | 23.09% |
| Q4 2023 | -1.03% |
| Q3 2023 | -0.44% |
| Q2 2023 | -1.74% |
| Q1 2023 | -3.27% |
| Q4 2022 | -7.78% |
| Q3 2022 | -4.56% |
| Q2 2022 | -0.74% |
| Q1 2022 | -5.29% |
| Q4 2021 | -3.90% |
| Q3 2021 | -1.73% |
| Q2 2021 | -3.97% |
| Q1 2021 | -1.76% |
| Q4 2020 | 0.00% |
| Q3 2020 | -0.43% |
| Q2 2020 | 30.41% |
| Q1 2020 | -0.06% |
| Q4 2019 | 73.01% |
| Q3 2019 | 2.96% |
| Q2 2019 | 0.27% |
| Q1 2019 | -6.82% |
| Q4 2018 | -0.49% |
| Q3 2018 | 9.16% |
| Q2 2018 | -0.48% |
| Q1 2018 | -0.22% |
| Q4 2017 | -1.13% |
| Q3 2017 | 1.50% |
| Q2 2017 | 0.77% |
| Q1 2017 | 0.30% |
| Q4 2016 | -1.25% |
| Q3 2016 | -1.41% |
| Q2 2016 | 18.59% |
| Q1 2016 | 0.76% |